Hydroquinazoline derivatives for the treatment of a disease or disorder
US12129246B1 · kind B1 · utility
0Cited by
1References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 2024 |
| Grant date | Oct 29, 2024 |
| Priority date | — |
| Expiry date | Feb 28, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof wherein A, Ra to Rd, and R4 to R7, are as described herein, as well as compositions and methods of using such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.